Beta Bionics (BBNX) Asset Writedowns and Impairment (2024 - 2025)
Beta Bionics (BBNX) posted Asset Writedowns and Impairment of $16000.0 for Q4 2025, down 33.33% sequentially from $24000.0 in Q3 2025, and down 38.46% YoY from $26000.0 in Q4 2024.
Beta Bionics (BBNX) Asset Writedowns and Impairment (2024 - 2025) Analysis & Trends
Beta Bionics has reported Asset Writedowns and Impairment for 2 years, with the latest figure at $16000.0 in Q4 2025.
- Quarterly Asset Writedowns and Impairment fell 38.46% year-over-year to $16000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $40000.0 (down 42.86% YoY) and the FY2025 annual result came in at $40000.0, down 42.86% from the prior year.
- Asset Writedowns and Impairment retreated to $16000.0 in Q4 2025 per BBNX's latest filing, from $24000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $27000.0 in Q2 2024 and troughed at $16000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | Beta Bionics | 837.47 Mn | 656.98 Mn | 18.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16,000.00 |
| Dec 31, 2025 | 16,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Mar 31, 2024 | 17,000.00 |